Grail (GRAL) Expected to Announce Earnings on Tuesday

Grail (NASDAQ:GRALGet Free Report) is expected to announce its earnings results before the market opens on Tuesday, February 11th. Analysts expect the company to announce earnings of ($4.41) per share for the quarter.

Grail (NASDAQ:GRALGet Free Report) last released its quarterly earnings data on Tuesday, November 12th. The company reported ($3.94) earnings per share for the quarter. The business had revenue of $28.65 million during the quarter. On average, analysts expect Grail to post $-65 EPS for the current fiscal year and $-15 EPS for the next fiscal year.

Grail Stock Performance

Shares of NASDAQ GRAL opened at $28.84 on Tuesday. The company has a 50 day simple moving average of $20.34 and a 200-day simple moving average of $16.64. Grail has a 1 year low of $12.33 and a 1 year high of $32.65.

Insider Buying and Selling

In other news, CFO Aaron Freidin sold 30,452 shares of the business’s stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $14.02, for a total transaction of $426,937.04. Following the sale, the chief financial officer now owns 268,277 shares of the company’s stock, valued at $3,761,243.54. The trade was a 10.19 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on the stock. Guggenheim started coverage on shares of Grail in a report on Thursday, October 17th. They issued a “neutral” rating on the stock. Morgan Stanley began coverage on Grail in a report on Wednesday, November 27th. They set an “equal weight” rating and a $16.00 price target for the company. Finally, Wolfe Research began coverage on Grail in a report on Friday, November 15th. They set a “peer perform” rating on the stock.

View Our Latest Stock Analysis on GRAL

About Grail

(Get Free Report)

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.

Recommended Stories

Receive News & Ratings for Grail Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Grail and related companies with MarketBeat.com's FREE daily email newsletter.